Ancestry, which grew from a genealogy tracking tool to offering DNA tests for a number of healthconditions, reached a deal to be acquired by Blackstone for $4.7 billion. But privacy advocates have raised concerns over the deal — namely, what would happen to users’ health data?
The demand has been so strong that consumer genetics company, AncestryDNA, now has a database of two million samples.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
23andMe can finally take a deep breath and move forward following FDA approval, and CEO Anne Wojcicki is doing just that.
Ancestry.com will study the genetics of human heredity in a new partnership with Calico - the Google-backed startup that aims to "cure death."
Ancestry.com's first offering, AncestryHealth, helps users track their genealogical predisposition to hereditary disease, but the company plans to expand this new health division well beyond family mapping.